Table 1.
Selected studies on radiofrequency ablation
| Study | Number of patients | Approach | Follow-up | Overall survival, median (months) | Progression free time (months) | Regression/stable disease rate (%) | Progression rate (%) | Recurrence rate (%) | Complications rate (%) | Mortality rate (%) |
|---|---|---|---|---|---|---|---|---|---|---|
| Giardino et al. (2015) [92] | 200 | Open | 1 year | 19 | 13 | NA | NA | NA | 24.5 (12.5 RFA-related) |
2.5 |
| Girelli et al. (2010) [8] | 50 | Open | Median: 8 months | NA | NA | NA | NA | NA | 24 | 2 |
| Fegrachi et al. (2019) [10] | 17 | Open | NA | 9 | NA | NA | NA | NA | 53% (36% RFA-related) |
6 |
| Frigerio et al. (2013) [12] | 57 | Open | 12 | 19 | 10 | 3.5 without radiological signs of disease, 12.2 stable disease |
12.3 | NA | 14 (3.5 procedure-related) |
0 |
| Giardino et al. (2012) [13] | 167 | Open | 18 months (n = 107) |
25.6 | NA | NA | NA | NA | 28 (17.7 RFA-related) |
1.8 |